Background {#Sec1}
==========

Quality by design (QbD) is an advanced drug quality control concept systematically described in Dr. Yu's work \[[@CR1]\]. Knowledge-based management and risk-based management are required in the application of the QbD concept \[[@CR2]\]. Recently, the QbD concept was successfully implemented in the optimization of manufacturing processes of Chinese medicines \[[@CR3]\] such as extraction \[[@CR4]\], precipitation \[[@CR5]\], chromatography \[[@CR6]\], decoloration \[[@CR7]\], drying \[[@CR8], [@CR9]\], granulation \[[@CR10]\], and so on.

In these works, critical process parameters (CPPs) were identified by risk analysis or statistical analysis \[[@CR11]\]. The relationships among CPPs, critical material attributes (CMAs), and process critical quality attributes (CQAs) were investigated using response surface designs \[[@CR12]\], such as central composite design or Box-Behnken design. After data collection, quadratic models were usually built \[[@CR13]\]. The design space was then calculated with the overlapping method or methods considering the probability to meet all process CQA limits \[[@CR14]\]. A control strategy for process parameters was developed, such as the recommendation of normal operation ranges of CPPs \[[@CR15]\] and the feedforward control of CPPs \[[@CR16]\]. However, the control strategy of material was rarely considered.

The variation of material attributes was considered to be the main source of drug quality variance for Chinese medicines \[[@CR17]\]. A set of proper manufacturing processes of Chinese medicines may reduce the variations introduced by materials. Therefore, the development of a material quality control strategy should consider the influences of manufacturing processes.

Wang et al. used central composite circumscribed design to simultaneously study the influences of materials and process parameters \[[@CR18]\]. However, the variety of raw materials was very limited. Ye et al. used fixed process parameters to treat different batches of *Salvia miltiorrhiza* to obtain the disodium salt of Salvianolic acid B \[[@CR19]\]. The quality standards of water extracts, which were the upstream intermediate, were set to ensure high purity Salvianolic acid B salt preparation \[[@CR19]\]. However, the standards of *Salvia miltiorrhiza* were not developed. Therefore, a new method to develop a material control strategy that considers the effects of manufacturing processes is still highly required.

Notoginseng total saponins (NTS), the material in the Xuesaitong injection, is a kind of herbal extract made from *Panax notoginseng* \[[@CR20]--[@CR22]\]. It is prepared with extraction, concentration, water precipitation, chromatography, decoloration, and drying \[[@CR23], [@CR24]\]. In this work, extractable saponin content and extractable dry matter content were considered as potential CMAs of *Panax notoginseng*. Definitive screening design was used to investigate the four processes of extraction, concentration, water precipitation, and chromatography simultaneously. Different materials were used in the experiments. After process CQAs were determined, CPPs and CMAs were identified simultaneously. Then, models implementing CMAs, CPPs, and process CQAs were developed. The design space was then calculated. A material control strategy considering the matching of manufacturing processes and materials was proposed. High quality and low quality *Panax notoginseng* can be discriminated by inequalities and can thus be processed differently. Verification experiments were carried out for high quality *Panax notoginseng*. Figure [1](#Fig1){ref-type="fig"} is a schematic diagram of the development of the material control strategy.Fig. 1Schematic diagram of the procedures for developing the material control strategy

Methods {#Sec2}
=======

Materials and chemicals {#Sec3}
-----------------------

Twenty batches of *Panax notoginseng* were collected from Yunnan Province of China. HPD-100 resin was purchased from Cangzhou Bon Adsorber Technology Co., Ltd. (Cangzhou, China). Reference substances of notoginsenoside R~1~, ginsenoside Rg~1~, ginsenoside Re, ginsenoside Rb~1~, and ginsenoside Rd were purchased from Shanghai Winherb Medical Technology Co., Ltd. (Shanghai, China). Acetonitrile (HPLC grade) was purchased from Merck (Darmstadt, Germany). Deionized water was prepared by an academic water purification system (Milli-Q, Milford, MA, USA). Ethanol (analytical grade) was purchased from Shanghai Lingfeng Chemical Reagent Co., Ltd. (Shanghai, China), and Sinophram Chemical Reagent Co., Ltd. (Shanghai, China).

Procedures {#Sec4}
----------

### Quality characterization of *Panax notoginseng* {#Sec5}

To characterize the material attributes, 100 g of *Panax notoginseng* was pulverized and reflux-extracted with 600 mL of an 80% (v/v) ethanol solution twice. The extraction time of each extraction was 6 h. The two extracts were obtained by filtration and then combined. Then, the concentrations of saponins and dry matter in the combined extract were analyzed. The extractable dry matter content (EDM~PN~) of *Panax notoginseng* was defined as Eq. [1](#Equ1){ref-type=""}.$$\documentclass[12pt]{minimal}
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                \begin{document}$$ EDM_{PN} = \frac{{M_{EX} \times DM_{EX} }}{{M_{PN} }} $$\end{document}$$where M and DM refer to the mass and dry matter concentration, respectively; the subscripts EX and PN refer to the combined extracts and *Panax notoginseng*, respectively. The extractable saponin content (ES~PN~) of *Panax notoginseng* was defined as Eq. [2](#Equ2){ref-type=""}.$$\documentclass[12pt]{minimal}
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                \begin{document}$$ ES_{PN,i} = \frac{{M_{EX} \times SC_{EX,i} }}{{M_{PN} }} $$\end{document}$$where SC refers to the saponin content; the subscript i where i is an integer value from 1 to 5 represents notoginsenoside R~1~, ginsenoside Rg~1~, ginsenoside Re, ginsenoside Rb~1~, and ginsenoside Rd, respectively. The extractable dry matter content and extractable saponin content were considered as potential CMAs of *Panax notoginseng* in this work.

### Extraction, concentration, and water precipitation processes {#Sec6}

*Panax notoginseng* (100 g) was pulverized and reflux-extracted with an ethanol solution twice. After extraction, the extracts were filtered and combined. The extracts were then concentrated under reduced pressure. The volume of concentrated extracts was controlled. Then, water was added to the concentrated extracts under magnetic stirring (85-1, Hangzhou Instrument Motor Co. Ltd., China). The mixtures were settled at room temperature for 1 h after stirring for 10 min. The supernatants of the water precipitation samples were collected by vacuum filtration. The five parameters of the ethanol solution concentration used for extraction, extraction time, ethanol solution volume, volume of concentrated extract, and water addition amount for water precipitation were investigated. Their coded and uncoded levels in the experiments are listed in Table [1](#Tab1){ref-type="table"}.Table 1Coded and uncoded values of parametersProcessParametersSymbolsCoded values− 101Ethanol extractionEthanol solution concentration for extraction (v/v %)X~1~808590Extraction time (h)X~2~6.08.010.0Ethanol solution volume (mL)X~3~6008001000ConcentrationVolume of concentrated extract (mL)X~4~100150200Water precipitationWater added for water precipitation (mL)X~5~300400500Column chromatographySampling flow rate (BV/h)X~6~1.01.52.0Washing flow rate (BV/h)X~7~1.01.52.0Water volume (BV)X~8~1.02.03.0Ethanol solution concentration for elution (v/v %)X~9~556065Elution time (min)X~10~120150180

### Column chromatography process {#Sec7}

A chromatography column was filled with 720 mL of HPD-100 microporous resin. The inner diameter of the column was 6 cm. Supernatants collected after water precipitation were passed through the column. A defined volume of water was then used to wash the column. After that, a volume of ethanol solution was used to elute the saponins. The elution flow rate was fixed at 1.0 BV/h. The eluate was collected for 30 min during elution in all experiments. The resin was regenerated with a 90% (v/v) ethanol solution at a flowrate of 1.5 BV/h for 80 min and then with water at 2 BV/h for 1.5 h. In the chromatography process, the five parameters of the sampling flow rate, washing flow rate, water volume, ethanol solution concentration used for elution, and elution time were investigated. Their coded and uncoded levels in the experiments can be seen in Table [1](#Tab1){ref-type="table"}.

### Experimental design {#Sec8}

In this work, a total of 10 parameters belonging to the 4 different processes of reflux extraction, concentration, water precipitation, and column chromatography were investigated simultaneously. To reduce the number of experiments, definitive screening design was used to investigate the influences of these manufacturing process parameters. Quadratic models can also be developed based on the definitive screening designed experiment results \[[@CR25]\]. Many process parameters can also be studied in a very small number of experiments \[[@CR25]\]. The experimental conditions are listed in Table [2](#Tab2){ref-type="table"}. To study the effects of raw materials, different batches of *Panax notoginseng* were used in these experiments, as shown in Table [2](#Tab2){ref-type="table"}.Table 2Conditions of definitive screening designed experimentsNo.*Panax notoginseng*X~1~ (v/v %)X~2~ (h)X~3~ (mL)X~4~ (mL)X~5~ (mL)X~6~ (BV/h)X~7~ (BV/h)X~8~ (BV)X~9~ (v/v %)X~10~ (min)1PN128510.010002005002.02.03.0651802PN7856.06001003001.01.01.0551203PN10908.010001005002.01.01.0551204PN2808.06002003001.02.03.0651805PN159010.08002003002.02.01.0551206PN3806.08001005001.01.03.0651807PN11906.010001505001.02.03.0551208PN108010.06001503002.01.01.0651809PN89010.06002004002.01.03.06512010PN11806.010001004001.02.01.05518011PN129010.010001005001.52.01.06518012PN14806.06002003001.51.03.05512013PN4906.010002003002.01.53.05518014PN98010.06001005001.01.51.06512015PN6906.06002005001.02.02.06512016PN88010.010001003002.01.02.05518017PN2906.06001005002.01.03.06018018PN168010.010002003001.02.01.06012019PN5906.06001003002.02.01.06515020PN68010.010002005001.01.03.05515021PN19010.06001003001.02.03.05518022PN4806.010002005002.01.01.06512023PN169010.010001003001.01.03.06512024PN15806.06002005002.02.01.05518025PN13906.010002003001.01.01.06518026PN78010.06001005002.02.03.05512027PN39010.06002005001.01.01.05518028PN13806.010001003002.02.03.06512029PN9858.08001504001.51.52.06015030PN14858.08001504001.51.52.06015031PN5858.08001504001.51.52.06015032PN1858.08001504001.51.52.060150

Analytical methods {#Sec9}
------------------

Dry matter content was measured using a precision electronic balance (AB204-N, Mettler Toledo Shanghai Co., Ltd). The samples were dried at 105 °C in an oven (DZF-6050, Shanghai Jing Hong Laboratory Instrument Co., Ltd.) for 3 h and then kept in a desiccator for 0.5 h. The quantitative analysis method for the determination of the saponin concentrations was reported in previous work \[[@CR26]\]. The method was performed on a Waters Acquity UPLC system (Waters, Milford, MA, USA) using a Waters CSH C18 column (50 mm × 2.1 mm i.d., 1.7 μm) at 40 °C. The mobile phase consisted of 0.01% formic acid--water (A) and 0.01% formic acid--acetonitrile (B) using the following gradient program: 0--6 min, 18--20% B; 6--6.8 min, 20--30% B; 6.8--11 min, 30--35% B; 11--17 min, 35--90% B; and 17--25 min, 90% B. The flowrate was 0.35 mL/min, and the volume of the sample injection was 5 μL. The detector wavelength was set to 203 nm.

Data processing {#Sec10}
---------------

The total saponin concentration (TSC) value in the extract or eluate was calculated with Eq. [3](#Equ3){ref-type=""}.$$\documentclass[12pt]{minimal}
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                \begin{document}$$ TSC = \sum\limits_{i = 1}^{5} {SC_{i}^{{}} } $$\end{document}$$

The total saponin yield (TSY) was defined as Eq. ([4](#Equ4){ref-type=""}).
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                \begin{document}$$ TSY = \frac{{M_{EL} \times TSC_{EL} }}{{M_{PN} }} $$\end{document}$$where the subscript EL refers to the eluate.

Dry matter yield (DMY) was calculated with Eq. ([5](#Equ5){ref-type=""}).$$\documentclass[12pt]{minimal}
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                \begin{document}$$ DMY = \frac{{M_{EL} \times DMC_{EL} }}{{M_{PN} }} $$\end{document}$$

Saponin purity (SP) values were calculated using Eq. [6](#Equ6){ref-type=""}.$$\documentclass[12pt]{minimal}
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The total saponin purity (TSP) value in the eluate was calculated with Eq. [7](#Equ7){ref-type=""}.$$\documentclass[12pt]{minimal}
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Design expert V8.0.6.1 (State-Ease Inc. MN) was used to analyze the results of the definitive screening designed experiments. To identify CPPs and CMAs, Eq. ([8](#Equ8){ref-type=""}) was used to model process parameters, quality attributes of *Panax notoginseng*, and process CQAs.
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                \begin{document}$$ Y = a_{0} + \sum\limits_{i = 1}^{11} {b_{i} X_{i} } + \sum\limits_{k = 1}^{7} {c_{k} Z_{k} } $$\end{document}$$where Y is a process CQA, X~i~ (i = 1--10) represents a process parameter, Z~k~ (k = 1--6) represents a material attribute, a~0~ is a constant, and b~i~ (i = 1--10) and c~k~ (k = 1--6) are regression coefficients. Stepwise regression was used to simplify the models. Insignificant variables were removed by stepwise regression. The significance levels for adding terms and removing terms were both set to 0.05. Any term remaining in the model was considered to represent a CPP or a CMA.

Then, CPPs' interactive sand square terms were added to establish predictive models for process CQAs, as seen in Eq. ([9](#Equ9){ref-type=""}).
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                \begin{document}$$ Y = a_{0} + \sum\limits_{i = 1}^{n} {b_{i} X_{i} } + \sum\limits_{i = 1}^{n} {b_{ii} X_{i}^{2} } + \sum\limits_{i = 1}^{n - 1} {\sum\limits_{j = i + 1}^{n} {b_{ij} X_{i} X_{j} } + } \sum\limits_{k = 1}^{m} {c_{k} Z_{k} } $$\end{document}$$where n is the number of CPPs and m is the number of CMAs. Stepwise regression was also performed as mentioned above.

A Monte Carlo method simulating the random error of experimental values was performed to calculate the design space. The detailed calculation processes are described in previous work \[[@CR27]\]. A brief description is given as follows: the experimental results were assumed to be normally distributed. The mean value of the normal distribution was assumed to be the measured response value. The relative standard deviation (RSD) of the normal distribution was fixed at 0.04. Random values representing experimental values were then created by the Monte Carlo simulation according to the normal distribution. These random values were modeled by Eq. [9](#Equ9){ref-type=""}. After each simulation, a new equation for a process CQA was obtained. The new equations developed from the Monte Carlo simulation values were used to calculate the predicted results. The probability of meeting all process CQA goals was then calculated based on the model prediction results. The design space was defined with a probability higher than 0.90. The simulation was performed 1000 times to obtain a probability-based design space. All calculations were carried out using MATLAB (R2016a, Version 9.0, The Math Works Inc., USA).

Results {#Sec11}
=======

Material attributes {#Sec12}
-------------------

The quality attributes of different *Panax notoginseng* batches are shown in Table [3](#Tab3){ref-type="table"}. For the extractable saponin contents, the ginsenoside Rg~1~ content was the highest, and the ginsenoside Re content was the lowest. For most materials, more than 100 mg/g *Panax notoginseng* of saponins can be extracted. The extractable dry matter contents were between 185 and 387 mg/g *Panax notoginseng.*Table 3Quality attributes of different batches of *Panax notoginseng*No.Extractable saponin content (mg/g *Panax notoginseng*)Extractable dry matter content (mg/g *Panax notoginseng*)\
(Z~6~)Notoginsenoside\
R~1~(Z~1~)Ginsenoside\
Rg~1~(Z~2~)Ginsenoside\
Re(Z~3~)Ginsenoside\
Rb~1~(Z~4~)Ginsenoside\
Rd(Z~5~)PN115.959.27.3552.914.0363PN28.4232.13.2130.46.99185PN314.353.97.7447.511.2355PN47.1833.44.6431.35.17216PN514.552.77.7951.811.0387PN613.352.48.3748.011.3342PN78.3134.64.5030.45.89192PN810.448.66.9543.97.89363PN913.449.48.2745.510.4337PN1013.347.57.6446.69.79356PN118.9938.54.4129.75.03224PN1212.446.87.8342.79.19357PN1314.548.36.3346.311.2304PN148.0436.04.3829.05.07197PN1515.151.76.4248.313.1341PN1614.855.77.1051.314.2316

Process CQA identification {#Sec13}
--------------------------

After analyzing the eluates collected after column chromatography, the process quality attributes were calculated and were determined to be saponin purities, total saponin yield, and dry matter yield in the eluates. As shown in Table [4](#Tab4){ref-type="table"}, the total saponin yield in the eluate was between 66.9 and 146 mg/g *Panax notoginseng.* Due to the removal of impurities, the dry matter yield was between 76.3 and 175 mg/g *Panax notoginseng,* which was significantly lower than the extractable dry matter of corresponding materials. Total saponin purity increased significantly to between 77.85 and 91.02%. The purity of ginsenoside Rd was between 3.15 and 8.58%.Table 4The quality attributes of the manufacturing processesNo.Saponin purity (%)Total saponin purity (%)Dry matter yield (mg/g *Panax notoginseng*)Total saponin yield (mg/g *Panax notoginseng*)Notoginsenoside\
R~1~Ginsenoside\
Rg~1~Ginsenoside\
ReGinsenoside\
Rb~1~Ginsenoside\
Rd18.6533.335.2330.196.6083.9914412129.1639.415.3730.073.6487.6576.366.939.4535.335.1930.404.7585.1214212148.6233.273.3832.517.6885.4690.277.1510.0035.675.3229.965.5686.5114012168.8535.774.4430.777.2887.10153133710.5942.975.2028.913.3491.0179.472.387.6029.954.5129.486.3277.8516613097.1134.974.8130.125.7082.70125103108.7538.884.7930.384.0686.8594.882.3118.2033.854.9929.436.5082.96126104129.7443.445.2829.853.1591.4780.773.8138.2937.195.3832.944.7488.5382.172.6148.5232.224.8429.926.7082.20143118158.2333.545.3030.397.1184.5711799.0167.3833.324.8830.874.8281.26148121178.8833.914.0830.937.4385.2382.570.3188.5432.324.4028.946.7980.99170137198.5231.384.6029.946.5781.01138111208.1533.325.4929.145.2881.38153125219.2235.014.8130.527.0286.57162140227.2334.684.9232.145.1884.1697.181.7238.7533.114.1829.527.7183.27166138249.7033.404.4329.546.5783.64152127259.6132.784.1331.228.5886.31137119269.0838.665.6130.373.9087.6191.079.8278.2333.985.6430.306.2184.37137116289.3531.694.0630.557.2682.92146121298.8633.545.2430.496.6584.79153130309.5740.205.2032.825.2393.0286.880.7318.2630.954.7929.165.9179.07168133328.8533.014.4529.757.4783.53175146

The dry matter yield mainly affects the economic benefits of pharmaceutical enterprises. By dividing saponin yield and dry matter yield, saponin purity can be calculated. Saponin purity represented the chemical composition of the process product. Therefore, saponin purity was considered a potential process for CQAs.

In the quality standards of the Xuesaitong injection, the purity of notoginsenoside R~1~, ginsenoside Rg~1~, ginsenoside Re, and ginsenoside Rb~1~ in the NTS should not be lower than 6%, 28%, 2.5%, and 26%, respectively. In Table [4](#Tab4){ref-type="table"}, the minimum purities of the above four saponins were 7.11%, 29.95%, 3.38%, and 28.91%, respectively. This means that these four process quality attributes easily attained their standards. Therefore, they were not considered as process CQAs. However, the minimum obtained Rd purity and total saponin purity were lower than that of their standards and were 3.5% and 85%, respectively. Therefore, Rd purity and total saponin purity were used as process CQAs.

The identification of CMAs and CPPs {#Sec14}
-----------------------------------

The linear regression results of Eq. [8](#Equ8){ref-type=""} and the corresponding ANOVA results are shown in Table [5](#Tab5){ref-type="table"}. The P value of each model was lower than 0.0001, indicating that the models were significant. The determination coefficients (R^2^) of all the models were higher than 0.70, which indicated that most of the data variances can be explained. It also indicated that the major influencing factors were probably included in the models. According to the P values, the ethanol solution concentration used for extraction, the ethanol solution concentration used for elution, and elution time were selected as CPPs. The extractable contents of notoginsenoside R~1~, ginsenoside Rg~1~, ginsenoside Rb~1~, and ginsenoside Rd of *Panax notoginseng* were CMAs. The extractable dry matter content of *Panax notoginseng* was also a CMA.Table 5Regression coefficients, R^2^ values and ANOVA results for the multiple linear regression modelsProcess parametersY~1~(Rd purity)Y~2~(Total saponin purity)Coefficientp valueCoefficientp valueConstant− 0.120.76X~1~3.382 × 10^−4^0.0394\*2.203 × 10^−3^0.0056\*\*X~9~1.824 × 10^−3^\< 0.0001\*\*X~10~1.869 × 10^−4^\< 0.0001\*\*Z~1~0.01030.0143\*Z~2~5.291 × 10^−3^0.0023\*\*Z~4~− 0.0111\< 0.0001\*\*Z~5~3.971 × 10^−3^\< 0.0001\*\*Z~6~− 8.607 × 10^−5^\< 0.0001\*\*Model p value\< 0.0001\< 0.0001R^2^0.93480.7460$\documentclass[12pt]{minimal}
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                \begin{document}$$ {\text{R}}^{ 2}_{\text{adj}} $$\end{document}$0.92230.7083\* p \< 0.05\*\* p \< 0.01

The effects of CMAs and CPPs {#Sec15}
----------------------------

Compared with Eq. [8](#Equ8){ref-type=""}, the nonlinear effects and interaction effects of CPPs were considered in Eq. [9](#Equ9){ref-type=""}, which was evaluated in this work. However, after stepwise regression, the terms representing nonlinear effects and interaction effects were all taken out of the models. This result indicated that only linear effects of CPPs were significant.

According to the regression coefficient values in Table [5](#Tab5){ref-type="table"}, higher ethanol concentrations in the extraction process resulted in higher ginsenoside Rd purity and total saponin purity. As the ethanol solution concentration used for elution and the elution time increased, the ginsenoside Rd purity increased. For CMAs, higher ginsenoside Rd and lower extractable dry matter content both led to a higher ginsenoside Rd purity in the eluate. Higher notoginsenoside R~1~, higher ginsenoside Rg~1~, and lower ginsenoside Rb~1~ purities all resulted in a higher purity of total saponins.

Design space development {#Sec16}
------------------------

The lower limits of Rd purity and total saponin purity were set according to the NTS standards of the Xuesaitong injection, which were 3.5% and 85%, respectively. Then, the design space was calculated, as shown in Fig. [2](#Fig2){ref-type="fig"}a and Additional file [1](#MOESM1){ref-type="media"}: Table S1. The design space was an irregular region.Fig. 2Three-dimensional design space and verification points (color bar refers to the probability of attaining the process CQA criteria; ○, verification points). **a** Material: PN7, **b** material: PN18, **c** material: PN20

Control strategy of *Panax notoginseng* {#Sec17}
---------------------------------------

To prepare satisfactory eluates, Inequalities 1 should be satisfied for Rd purity and total saponin purity.
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                \begin{document}$$ \left\{ \begin{aligned} & b_{1}^{1} X_{1} + b_{9}^{1} X_{9} + b_{10}^{1} X_{10} + c_{5}^{1} Z_{5} + c_{6}^{1} Z_{6} + a_{0}^{1} \ge 3.5\% \hfill \\ & b_{1}^{2} X_{1} + c_{1}^{2} Z_{1} + c_{2}^{2} Z_{2} + c_{4}^{2} Z_{4} + a_{0}^{2} \ge 85.0\% \hfill \\ \end{aligned} \right. $$\end{document}$$where superscript 1 and 2 refer to Rd purity and total saponin purity, respectively. The values of regression coefficients in Inequalities 1 can be found in Table [5](#Tab5){ref-type="table"}. In principle, different batches of *Panax notoginseng* can be divided into two grades according to Inequalities 1. If the CMAs of a batch of *Panax notoginseng* meet Inequalities 1, the batch of *Panax notoginseng* is considered to be acceptable material if the process parameters can be varied within the investigated ranges. In contrast, if Inequalities 1 is unattainable, the batch of *Panax notoginseng* is considered to be unacceptable and cannot be released for NTS production. For a batch of acceptable *Panax notoginseng*, feasible process parameters can be chosen after calculation or selected from Additional file [1](#MOESM1){ref-type="media"}: Table S1.

However, in the current traditional Chinese medicine TCM industry, raw materials are usually treated with a set of fixed manufacturing process parameters because of the limitation of regulations. In this case, the quality control of raw material should be stricter.

For example, the manufacturing process parameters were fixed as follows: the ethanol solution concentration for extraction was 88%, the extraction time was 6 h, the ethanol solution addition was 6.72 mL/g *Panax notoginseng*, the volume of concentrated extract was 1.31 mL/g *Panax notoginseng*, and the water addition for water precipitation was 3.73 mL/g *Panax notoginseng*. The sampling flow rate was 1.7 BV/h, the washing sampling flow rate was 1.8 BV/h, the washing volume was 2.0 BV, the ethanol solution concentration for elution was 56%, and the elution time was 133 min.

Inequalities 1 can then be simplified to Inequalities 2.$$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \left\{ \begin{aligned} &397Z_{5} - 8.61Z_{6} + 730 \ge 0 \hfill \\ &10.3Z_{1} + 5.291Z_{2} - 11.1Z_{4} + 108.3 \ge 0 \hfill \\ \end{aligned} \right. $$\end{document}$$

Then, Inequalities 2 can be used to divide different batches of *Panax notoginseng* into two grades. A batch of *Panax notoginseng* with CMAs meeting Inequalities 2, this batch of *Panax notoginseng* is considered to be high quality material for the current parameter fixing process. If a batch of *Panax notoginseng* with CMAs does not meet Inequalities 2, it is considered a low-quality material and should not be released for NTS production.

Examples of material quality control and verification experiments {#Sec18}
-----------------------------------------------------------------

The CMAs of 4 batches of *Panax notoginseng* were measured and are shown in Table [6](#Tab6){ref-type="table"}. According to Inequalities (1), *Panax notoginseng* of PN17 and PN19 were low quality *Panax notoginseng*, and they should not be directly used in production. However, PN17 and PN19 were probably qualified materials because their saponin contents met the standards in Chinese Pharmacopeia (1st Section, 2015 Edition). If they were qualified materials, they can also be used in the existing manufacturing processes after proper mixing with other qualified batches of *Panax notoginseng* to form a new batch.Table 6Material attributes of *Panax notoginseng*Notoginsenoside\
R~1~(Z~1~)Ginsenoside\
Rg~1~(Z~2~)Ginsenoside\
Rb~1~(Z~4~)Ginsenoside\
Rd(Z~5~)PN176.5537.135.97.19242Low qualityPN188.0538.734.07.41241High qualityPN198.6751.646.87.42312Low qualityPN209.0938.732.36.43227High quality

PN18 and PN20 were high quality *Panax notoginseng* batches. The verification experiment conditions were as follows: for PN18, the fixed process parameters mentioned in "[Control strategy of *Panax notoginseng*](#Sec17){ref-type="sec"}" section were used. For PN 20, the ethanol concentration was 90% (v/v), the extraction time was 10 h, the ethanol solution addition was 6.0 mL/g *Panax notoginseng*, the volume of the concentrate was 1.5 mL/g *Panax notoginseng*, the water addition for water precipitation was 3 mL/g *Panax notoginseng*, the sampling flow rate was 1.0 BV/h, the water volume was 1 BV, the ethanol solution concentration for elution was 60% (v/v), and the elution time was 120 min. The results are listed in Table [7](#Tab7){ref-type="table"}. All the indices met the standards of NTS of the Xuesaitong injection. The prediction results were close to the experimental results, indicating that the models were accurate.Table 7Results of verification experimentsNo.No.Saponin purity (%)Total saponin purity (%)Notoginsenoside\
R~1~Ginsenoside\
Rg~1~Ginsenoside\
ReGinsenoside\
Rb~1~Ginsenoside\
RdPN18111.2937.445.2630.465.0689.51211.4737.035.9032.005.5391.92312.2938.506.2431.745.2394.00Predicted values--------4.7086.50PN20110.04414.4730.75.4791.69210.51434.6131.15.294.3939.7740.14.7230.75.2490.58Predicted values--------4.8389.81

Discussion {#Sec19}
==========

The selection of potential CMAs {#Sec20}
-------------------------------

Potential CMAs can be physical, chemical, and biological features of *Panax notoginseng.* Considering that NTS is mainly composed of five saponins, their contents in *Panax notoginseng* should be potential CMAs. The method to analyze saponin contents in *Panax notoginseng* can be found in Chinese Pharmacopeia (1st Section, 2015 Edition) and other publications \[[@CR28]--[@CR30]\]. *Panax notoginseng* needs to be pulverized into a powder and extracted with methanol or a methanol solution in these works. However, *Panax notoginseng* will not be pulverized as finely in industry processes. The extraction solvent is an ethanol solution instead of a methanol solution. This means that the saponins extracted in an industrial process may be less than that in an analytical laboratory for the same material. Therefore, extractable saponin content was used in this work as a potential CMA.

In addition to the abovementioned five saponins, there are many other components in *Panax notoginseng*. However, only the components that can be extracted by the ethanol solution may affect the composition of NTS. Therefore, extractable dry matter was used as another potential CMA in this work. The usage of extractable dry matter also avoided the difficulties in measuring low content components in *Panax notoginseng*. Extractable dry matter and extractable saponin content were measured after extraction experiments with conditions similar to industrial conditions.

The reduction of CPP number {#Sec21}
---------------------------

In this work, three CPPs were identified for four processes: the ethanol solution concentration used for extraction, the ethanol solution concentration used for elution, and the elution time. If these processes were studied separately, as in previous works \[[@CR6], [@CR13], [@CR31], [@CR32]\], there were more than 10 CPPs. These results indicated that CPP number can be reduced if several processes are studied simultaneously. A lower CPP number means that the design of the process control strategy can be simplified. There is no CPP in water precipitation and concentration, which means that these processes are not critical processes. This conclusion also agreed well with Zhong et al.'s work \[[@CR33]\] and He's work \[[@CR34]\].

The relationship of material control strategy and regulations {#Sec22}
-------------------------------------------------------------

In the current industry, manufacturing process parameters are fixed despite the variation of herbal material quality on most occasions. However, in principle, process parameters can vary within their ranges declared by drug regulatory authorities. However, if the declared ranges of manufacturing process parameters are very narrow, the variation of process parameters will be difficult. Although the application for changing a manufacturing process is an option, the cost for Type II and Type III change is usually not economically feasible. Therefore, strict control of the quality of medicinal materials becomes the better option. An example of determining material quality standards for the parameter fixing process is given in "[Control strategy of *Panax notoginseng*](#Sec17){ref-type="sec"}" section.

The disadvantages of the present method {#Sec23}
---------------------------------------

Equation [9](#Equ9){ref-type=""} was used to model CMAs, CPPs, and process CQAs \[[@CR35]\]. However, the interaction between CMAs and CPPs was not considered. The nonlinear effects of CMAs were also ignored. After stepwise regression, the interaction between CPPs was not found. A main reason is that the experimental number was not large enough after using the current experimental design.

Extractable dry matter content and five extractable saponin contents were considered potential CMAs. However, some CMAs may be missing. Although different batches of *Panax notoginseng* were used, the representativeness of material quality may still be insufficient.

Conclusion {#Sec24}
==========

In this work, the manufacturing processes of extraction, concentration, water precipitation, and chromatography for NTS production were studied with the consideration of *Panax notoginseng* quality variation. A definitive screening design was used for the study of 10 process parameters. Different materials were used in the experiments. Extractable saponin contents and extractable dry matter content were considered potential CMAs. The purity of ginsenoside Rd and the purity of total saponins were selected as process CQAs. The ethanol solution concentration used for extraction, the ethanol solution concentration used for elution, and elution time were selected as CPPs. Extractable dry matter content and extractable contents of notoginsenoside R~1~, ginsenoside Rg~1~, ginsenoside Rb~1~, and ginsenoside Rd were CMAs. Quantitative models of CPPs, CMAs, and process CQAs were obtained. The design space was then calculated using a Monte Carlo simulation method with an acceptable probability of 0.90. High quality and low quality *Panax notoginseng* can be discriminated with Inequalities 1. Low quality *Panax notoginseng* should not be directly used in production. High-quality *Panax notoginseng* can be treated with feasible process parameters. Verification experiments were carried out for high quality *Panax notoginseng.* The prediction results agreed well with the experimental results, indicating that the models were accurate. In this work, a quality control strategy of raw *Panax notoginseng* material was developed considering the matching of manufacturing process characteristics and material quality attributes. A similar strategy can also be applied to other Chinese medicines.
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**Additional file 1: Table S1.** Design space and calculated probability.
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EX

:   combined extracts

PN

:   *Panax notoginseng*

EL

:   eluate
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